Cargando…
Immunotherapy and Chemotherapy Versus Sleep Disturbances for NSCLC Patients
Introduction: Cancer patients are known to experience sleep disturbances that differ between disease stages and treatments. Regarding lung cancer patients and immunotherapy, information on their sleep disturbances has been recently acquired, but no comparison has been made between different treatmen...
Autores principales: | Zarogoulidis, Paul, Petridis, Dimitrios, Kosmidis, Christoforos, Sapalidis, Konstantinos, Nena, Lila, Matthaios, Dimitrios, Porpodis, Konstantinos, Kakavelas, Paschalis, Steiropoulos, Paschalis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955782/ https://www.ncbi.nlm.nih.gov/pubmed/36826116 http://dx.doi.org/10.3390/curroncol30020155 |
Ejemplares similares
-
Non-Small-Cell Lung Cancer Immunotherapy and Sleep Characteristics: The Crossroad for Optimal Survival
por: Zarogoulidis, Paul, et al.
Publicado: (2023) -
Biomarkers to Improve Diagnosis and Monitoring of Obstructive Sleep Apnea Syndrome: Current Status and Future Perspectives
por: Archontogeorgis, Konstantinos, et al.
Publicado: (2014) -
Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G
por: Zarogoulidis, Paul, et al.
Publicado: (2021) -
Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy
por: Katopodi, Theodora, et al.
Publicado: (2022) -
Predictors of Sleep Duration and Sleep Disturbance in Children of a Culturally Diverse Region in North-Eastern Greece
por: Nena, Evangelia, et al.
Publicado: (2020)